The effect of secukinumab on non-radiographic axial spondyloarthritis at 2 years
A simplified overview of the abstract presented at EULAR June 2, 2021
Secukinumab effect across the axial spondyloarthritis spectrum at 1 year
A simplified overview of the abstract presented at EULAR June 3, 2021.
Using sensitive ultrasound imaging to understand response of psoriatic arthritis to secukinumab over 24 weeks
A simplified overview of the abstract presented at EULAR June 4, 2021.
Secukinumab effect in two types of arthritis seen in children and adolescents at two years
A simplified overview of the abstract presented at EULAR June 5, 2021.